Discriminative-stimulus effects of morphine in combination with α-and β-noradrenergic agonists and antagonists in rats

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 979-986

  Hughes, Christine E ^a   Habash, Tina ^a   Dykstra, Linda A ^a,b   Picker, Mitchell J ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Clonidine; Drug discrimination; Fixed ratio schedule; Morphine; Noradrenergic; Prazosin; Propranolol; Rats; Salbutamol; Yohimbine

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; MORPHINE; PRAZOSIN; PROPRANOLOL; SALBUTAMOL; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; FOOD; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT;

ADRENERGIC AGENTS; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; NARCOTICS; NOREPINEPHRINE; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0029886419     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02151-5     Document Type: Article

References (40)

1. 2 agonists in rats. Pharmacol. Toxicol. 64:165-172; 1989.
2. Aston-Jones, G.; Rajkowski, J.; Kubiak, P.; Akaoka, H. Acute morphine induces oscillatory discharge of noradrenergic locus coeruleus neurons in the waking monkey. Neurosci. Lett. 140: 219-224; 1992.
3. 3H]noradrenaline from SH-SY5Y human neuroblastoma cells. Br. J. Anaesth. 72:98-103; 1994.
4. 2-receptors on various test systems. Br. J. Pharmacol. 77:487-491; 1982.
5. Charney, D. S.; Riordan, C. E.; Kleber, H. D.; Murburg, M.; Braverman, P.; Sternberg, D. E.; Heninger, G. R.; Redmond, E. Clonidine and naltrexone: A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Arch. Gen. Psychiatry 39:1327-1332; 1982.
6. Dwoskin, L. P.; Neal, B. S.; Sparber, S. B. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats. Eur. J. Pharmacol. 90:269-273; 1983.
7. Fielding, S.; Wikler, J.; Hynes, M.; Szewczak, M.; Novick, W. J.; Lal, H. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions. J. Pharmacol. Exp. Ther. 207:899-905; 1978.
8. Gold, M. S.; Redmond, D. E., Jr.; Kleber, H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 16:599-602; 1978.
9. Holtzman, S. G. Discriminative stimulus effects of morphine withdrawal in the dependent rat: Suppression by opiate and non-opiate drugs. J. Pharmacol. Exp. Ther. 233:80-86; 1985.
10. Iglesias, V.; Alguacil, L. F.; Alamo, C.; Cuenca, E. Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur. J. Pharmacol. 211:35-38; 1992.
11. Jaeger, T. V.; Van der Kooy, D. Morphine acts in the parabrachial nucleus, a pontine viscerosensory relay, to produce discriminative stimulus effects. Psychopharmacology (Berlin) 110:76; 1993.
12. Jasinski, D. R.; Johnson, R. E.; Kocker, T. R. Clonidine in morphine withdrawal. Differential effects on signs and symptoms. Arch. Gen. Psychiatry 42:1063-1066; 1985.
13. Katz, J. L. Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology (Berlin) 88:392-397; 1986.
14. 3H]-norepinephrine release in the human neuroblastoma cell-line SK-N-SH. Brain Res. 646:319-323; 1994.
15. Kosten, T. A. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur. J. Pharmacol. 254:59-63; 1994.
16. Krimmer, E. C.; McGuire, M. S.; Barry, H., III. Effects of training dose on generalization of morphine stimulus to clonidine. Pharmacol. Biochem. Behav. 20:669-673; 1984.
17. Lal, H.; Gianutsos, G.; Miksic, S. Discriminable stimuli produced by analgesics. In: Lal, H., ed. Discriminative stimulus properties of drugs. Advances in behavioral biology. Vol. 22. New York: Plenum Press; 1977:23-45.
18. Locke, K. W.; Holtzman, S. G. Characterization of the discriminative stimulus effects of centrally administered morphine in the rat. Psychopharmacology (Berlin) 87:1-6; 1985.
19. Matsumoto, M.; Yoshioka, M.; Togashi, H.; Hirokami, M.; Tochihara, M.; Ikeda, T.; Smith, C. B.; Saito, H. mu-Opioid receptors modulate noradrenaline release from the rat hippo-campus as measured by brain microdialysis. Brain Res. 636:1-8; 1994.
20. Middlemess, D. N.; Blakeborough, L.; Leather, S. R. Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor. Nature 267:289-291; 1977.
21. Miksic, S.; Shearman, G.; Lal, H. Generalization study with some narcotic and nonnarcotic drugs in rats trained for morphine-saline discrimination. Psychopharmacology (Berlin) 60: 103-104; 1978.
22. Milne, B.; Cervenko, F. W.; Jhamandas, K.; Loomis, C.; Sutak, M. Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat. Pain 22:165-172; 1985.
23. Nahorski, S. R.; Willcocks, A. L. Interaction of β-adrenoceptor antagonists with 5-hydroxytryptamine receptor subtypes in rat cerebral cortex. Br. J. Pharmacol. 78:107P; 1983.
24. Ossipov, M. H.; Harris, S.; Lloyd, P.; Messineo, E. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J. Pharmacol. Exp. Ther. 255:1107-1116; 1990.
25. Paalzow, G. Development of tolerance to the analgesic effects of clonidine in rats cross-tolerant to morphine. Naunyn Schmiedebergs Arch. Pharmacol. 304:1-4; 1978.
26. Picker, M. J.; Doty, P.; Negus, S. S.; Mattox, S. R.; Dykstra, L. A. Discriminative stimulus properties of U50,488 and morphine: Effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J. Pharmacol. Exp. Ther. 254:13-22; 1990.
27. Powell, K. R.; Picker, M. J.; Dykstra, L. A. Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats. Behav. Pharmacol. 5: 255-264; 1994.
28. 2 receptors. J. Pharmacol. Exp. Ther. 262:365-262; 1992.
29. Schnur, P.; Espinoza, M.; Flores, R.; Ortiz, S.; Vallejos, S.; Wainwright, M. Blocking naloxone-precipitated withdrawal in rats and hamsters. Pharmacol. Biochem. Behav. 43:1093-1098; 1992.
30. Shannon, H. E.; Holtzman, S. G. Morphine training dose: A determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology (Berlin) 61:239-244; 1979.
31. Shoaib, M.; Spanagel, R. Mesolimbic sites mediate the discriminative stimulus effects of morphine. Eur. J. Pharmacol. 252:69-75; 1994.
32. Sklair-Tavron, L.; Nestler, E. J.; Segal, M. Locus coeruleus (LC)-Target interaction and cAMP in control of LC development. Brain Res. Bull. 35:397-401; 1994.
33. Solomon, R. E.; Gebhart, G. F. Intrathecal morphine and clonidine: Antinociceptive tolerance and cross-tolerance and effects on blood pressure. J. Pharmacol. Exp. Ther. 245:444-454; 1988.
34. 2 agonists in rats: Tolerance and cross-tolerance studies. J. Pharmacol. Exp. Ther. 244:63-70; 1988.
35. Taylor, J. R.; Lewis, V. O.; Elsworth, J. D.; Pivirotto, P.; Roth, R. H.; Redmond, D. E., Jr. Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats. Psychopharmacology (Berlin) 103:407-414; 1991.
36. la receptor. Eur. J. Pharmacol. 133:47-56; 1987.
37. Werling, L. A.; Brown, S. R.; Cox, B. M. Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology 26:987-996; 1987.
38. Wilcox, G. L.; Carlsson, K. H.; Jochim, A.; Jurna, I. Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain. Res. 405:84-93; 1987.
39. Young, A. M.; Masaki, M. A.; Geula, C. Discriminative stimulus effects of morphine: Effects of training dose on agonist and antagonist effects of mu opioids. J. Pharmacol. Exp. Ther. 261: 246-257; 1992.
40. Young, A. M.; Sannerud, C. A.; Steigerwald, E. S.; Doty, M. D.; Lipinski, W. J.; Tetrick, L. E. Tolerance to morphine stimulus control: Role of morphine maintenance dose. Psychopharmacology (Berlin) 102:59-67; 1990.